Inventor · disambiguated record
Lisa Diana Macdonald
Also filed as: MACDONALD LISA · MACDONALD LISA DIANA
6 granted patents·6 pending applications·8 citations·filing 2009–2022
74Inventor score
Top patents by PatentIndex Score
12 records- 0179US10105435B2Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2012·Granted Oct 23, 2018·5 cites·20 claims
- 0276US11406705B2Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjectsIMMUNOVACCINE TECHNOLOGIES INC·Filed 2016·Granted Aug 9, 2022·2 cites·20 claims
- 0367US12042537B2Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjectsBIOVAXYS INC·Filed 2022·Granted Jul 23, 2024·0 cites·19 claims
- 0466US11160861B2Adjuvanting systems and water-free vaccine compositions comprising a polyI:C polynucleotide adjuvant and a lipid-based adjuvantIMMUNOVACCINE TECHNOLOGIES INC·Filed 2016·Granted Nov 2, 2021·1 cites·28 claims
- 0565US11717563B2Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substanceIMMUNOVACCINE TECHNOLOGIES INC·Filed 2019·Granted Aug 8, 2023·0 cites·26 claims
- 0665US11077184B2Liposome compositions comprising PAM2Cys or PAM3Cys adjuvant and methods for inducing a humoral immune responseIMMUNOVACCINE TECHNOLOGIES INC·Filed 2018·Granted Aug 3, 2021·0 cites·21 claims
- 0765US2011070298A1Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic SubstanceIMMUNOVACCINE TECHNOLOGIES INC·Filed 2009·Application pending·0 cites
- 0864US2021308252A1Liposome compositions comprising pam2cys or pam3cys adjuvant and methods for inducing a humoral immune responseIMMUNOVACCINE TECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 0961US2024390468A1Survivin and mage-a9 dual-targeted immunotherapyIMMUNOVACCINE TECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1058US2022001010A1Adjuvanting systems and water-free vaccine compositions comprising a polyi:c polynucleotide adjuvant and a lipid-based adjuvantIMMUNOVACCINE TECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 1151US2022125903A1Methods for improving the efficacy of a survivin therapeutic in the treatment of tumorsIMMUNOVACCINE TECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 1240US2018162913A1Methods for potentiating an immune response using depot-forming and non-depot-forming vaccinesIMMUNOVACCINE TECHNOLOGIES INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →